Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Current Assets (2019 - 2025)

Historic Current Assets for Biodesix (BDSX) over the last 7 years, with Q3 2025 value amounting to $33.4 million.

  • Biodesix's Current Assets fell 2411.8% to $33.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $33.4 million, marking a year-over-year decrease of 2411.8%. This contributed to the annual value of $39.5 million for FY2024, which is 50.15% down from last year.
  • As of Q3 2025, Biodesix's Current Assets stood at $33.4 million, which was down 2411.8% from $32.4 million recorded in Q2 2025.
  • In the past 5 years, Biodesix's Current Assets registered a high of $81.2 million during Q1 2021, and its lowest value of $24.1 million during Q3 2022.
  • In the last 5 years, Biodesix's Current Assets had a median value of $35.1 million in 2022 and averaged $41.2 million.
  • Its Current Assets has fluctuated over the past 5 years, first skyrocketed by 21100.89% in 2021, then plummeted by 6648.0% in 2022.
  • Biodesix's Current Assets (Quarter) stood at $43.6 million in 2021, then rose by 22.29% to $53.3 million in 2022, then dropped by 25.6% to $39.7 million in 2023, then dropped by 0.5% to $39.5 million in 2024, then decreased by 15.41% to $33.4 million in 2025.
  • Its Current Assets was $33.4 million in Q3 2025, compared to $32.4 million in Q2 2025 and $29.6 million in Q1 2025.